SARS-CoV-2 Neutralizing Antibody
Detection Kit

Home » Rapid Tests » SARS CoV-2 Neutralizing Antibody Detection Kit

Overview

GenScript’s SARS-CoV-2 Neutralizing Antibody Detection Kit uses novel technology to detect antibodies specific to the spike protein receptor binding domain (S-RBD) of the SARS-CoV-2 virus responsible for COVID-19. Antibodies to this specific antigen are generated by the body via two methods 1) natural infection or 2) vaccination. The S-RBD is the critical viral component used by the virus to enter human cells and is the primary target used in vaccine development to elicit a specific immune response. Detecting the presence of the neutralizing antibodies is the first step in determining whether there is an adaptive immune response!

Placing An Order

SARS-CoV-2 Neutralizing Antibody Detection Kit

Version

CE 1434

RUO

Size

1 test/kit

5 tests/kit

25 tests/kit

Quantity

Get A Quote

The neutralizing antibody test uses novel technology to detect antibodies specific to the spike receptor binding domain (S-RBD). Antibodies to this specific antigen are generated by the body by either natural infection or vaccination as the S-RBD is the critical viral component used by the virus to enter human cells and is the primary target used in vaccine development.

Product Details

Product Introduction
Specifications

Each kit provides the necessary materials for the test, including:

Individually packaged test cards

Sample buffer

Lancet device

Capillary collection tube

Alcohol pad

This test provides a Qualitative result.

Sample type: Blood, serum or plasma by venous collection or fingerprick blood sample

Store at 4-30°C until use

18 month shelf life
Recommended usage
- This test does not diagnose a SARS-CoV-2 infection.
- The CE-IVD at-home authorization is a non-prescription EU authorization that allows individuals to evaluate their immune response to COVID-19 vaccination or infection in a home-based setting.
- The test is also offered in a Research Use Only format, where applicable, and is not to be used in diagnostic procedures.
Product Benefits

Less invasive method to monitor patient recovery

Results in 15 minutes

Multiple use scenarios including immune passport, workplace testing, and individual vaccine efficacy evaluation

Includes colorimetric card for enhanced qualitative interpretation
Test Principle

Performance

Samples from a cohort of patients were tested using the SARS-CoV-2 Neutralizing Antibody Rapid Test Kit. The combined cohort consisted of samples from normal healthy people (n= 25) and samples from confirmed SARS-CoV-2 positive patients (n=25) based on plaque reduction neutralization test (PRNT) results.